Antabio SAS, a biopharmaceutical company developing novel antibacterial treatments in areas of highest unmet needs, announced today the completion of a €7.3M series A...

MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient has been dosed in its pivotal Phase 3 clinical trial assess...

UK-based Motif Bio reported that its skin disorder drug iclaprim has succeeded in a second phase 3 trial in patients with acute bacterial skin and skin structure infe...

Bayer, along with its development partner Janssen Research & Development, has halted the phase III Navigate ESUS study of rivaroxaban (Xarelto), as it demonstrate...

NanOlogy has commenced the Phase 2 clinical study of intraperitoneally (IP) administered NanoPac (nanoparticle paclitaxel) to treat ovarian cancer. The company has re...

Shield Therapeutics has completed enrollment of the Phase 3 AEGIS-CKD clinical trial of its European-marketed product, Feraccru. Top-line data, based on the 16-week p...

The first patients have now enrolled in AIRWISE, the world’s largest ever pragmatic clinical trial in chronic obstructive pulmonary disease (COPD) to study how common...

The monoclonal antibody HIV drug ibalizumab, designed for patients who've developed severe drug resistance, had long-lasting protection in the 24-week extension phase...

Healthy volunteers study initiated for OATD-01, an innovative therapy for the treatment of asthma OncoArendi Therapeutics announced today that this week the Company w...

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the b...